Acrivon Therapeutics

Cambridge, United States

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Apr 2024

Post-IPO Equity

Biotechnology Health Care Oncology Therapeutics

Top Investors

RA Capital ManagementWellington ManagementSands Capital VenturesNew Enterprise AssociatesPerceptive Advisors

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Acrivon Therapeutics

Who are Acrivon Therapeutics's investors?

Acrivon Therapeutics's investors include RA Capital Management, Wellington Management, Sands Capital Ventures, New Enterprise Associates, Perceptive Advisors.

Where is Acrivon Therapeutics headquartered?

Acrivon Therapeutics is headquartered in Cambridge, United States.

What does Acrivon Therapeutics do?

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

What stage is Acrivon Therapeutics at?

Acrivon Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 9, 2024.

MLA

"Acrivon Therapeutics — Funding & Investors." VCBacked, April 9, 2024, https://www.vcbacked.co/company/acrivon-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2024). Acrivon Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/acrivon-therapeutics

Wikipedia (cite web)

{{cite web |title=Acrivon Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/acrivon-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 9, 2024.